BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8857820)

  • 1. Oncogene-related serum proteins and cancer risk: a nested case-control study.
    Weissfeld JL; Larsen RD; Niman HL; Kuller LH
    Am J Epidemiol; 1996 Oct; 144(8):723-7. PubMed ID: 8857820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of oncogene-related proteins in serum.
    Weissfeld JL; Larsen RD; Niman HL; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):57-62. PubMed ID: 8118387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study.
    Gormally E; Vineis P; Matullo G; Veglia F; Caboux E; Le Roux E; Peluso M; Garte S; Guarrera S; Munnia A; Airoldi L; Autrup H; Malaveille C; Dunning A; Overvad K; Tjønneland A; Lund E; Clavel-Chapelon F; Boeing H; Trichopoulou A; Palli D; Krogh V; Tumino R; Panico S; Bueno-de-Mesquita HB; Peeters PH; Pera G; Martinez C; Dorronsoro M; Barricarte A; Navarro C; Quirós JR; Hallmans G; Day NE; Key TJ; Saracci R; Kaaks R; Riboli E; Hainaut P
    Cancer Res; 2006 Jul; 66(13):6871-6. PubMed ID: 16818665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum selenium and cancer mortality: a nested case-control study within an age- and sex-stratified sample of the Belgian adult population.
    Kornitzer M; Valente F; De Bacquer D; Neve J; De Backer G
    Eur J Clin Nutr; 2004 Jan; 58(1):98-104. PubMed ID: 14679373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is serum selenium a risk factor for cancer in men only?
    Kok FJ; de Bruijn AM; Hofman A; Vermeeren R; Valkenburg HA
    Am J Epidemiol; 1987 Jan; 125(1):12-6. PubMed ID: 3788940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogene and tumor-suppressor gene products as serum biomarkers in occupational-derived lung cancer.
    Helmig S; Schneider J
    Expert Rev Mol Diagn; 2007 Sep; 7(5):555-68. PubMed ID: 17892364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.
    Bergh JC
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S20-6. PubMed ID: 2174659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
    J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of oncogene products as tumour markers.
    Chan S; Sikora K
    Cancer Surv; 1987; 6(2):185-207. PubMed ID: 3322544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
    Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Hsing AW; Crawford ED; Andriole GL; Kaaks R; Hayes RB
    Int J Cancer; 2008 May; 122(10):2345-50. PubMed ID: 18172860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasectomy and prostate cancer: a case-control study in India.
    Platz EA; Yeole BB; Cho E; Jussawalla DJ; Giovannucci E; Ascherio A
    Int J Epidemiol; 1997 Oct; 26(5):933-8. PubMed ID: 9363512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cellular oncogenes in primary cells from human acute leukemias.
    Mavilio F; Sposi NM; Petrini M; Bottero L; Marinucci M; De Rossi G; Amadori S; Mandelli F; Peschle C
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4394-8. PubMed ID: 3520570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does a family history of cancer increase the risk for postmenopausal endometrial carcinoma? A prospective cohort study and a nested case-control family study of older women.
    Olson JE; Sellers TA; Anderson KE; Folsom AR
    Cancer; 1999 Jun; 85(11):2444-9. PubMed ID: 10357416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.